Latest News about GILD
Recent news which mentions GILD
US Stock To Likely Open Lower Amid Tariff Tensions: Expert Hints Sans Lower Tariffs It's Hard To See The 'Market Going Up'
February 11, 2025
From Benzinga
Earnings Scheduled For February 11, 2025
February 11, 2025
From Benzinga
Nasdaq Gains 1% As Nvidia, Broadcom Surge: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone
February 11, 2025
From Benzinga
From Benzinga
What To Expect When Biotech Giant Gilead Reports Q4 Earnings On Tuesday?
February 10, 2025
From Benzinga
Gilead Sciences Options Trading: A Deep Dive into Market Sentiment
February 10, 2025
Tickers
GILD
From Benzinga
3 Fabulous Dividend Stocks to Buy in February
February 09, 2025
From Motley Fool
These 2 Dividend Stocks Are Absolute Bargains Right Now
February 08, 2025
From Motley Fool
3 Top AI-Powered Biotech Stocks to Buy in February
February 06, 2025
From Motley Fool
From Benzinga
From Benzinga
Looking At Gilead Sciences's Recent Unusual Options Activity
January 29, 2025
Tickers
GILD
From Benzinga
Breaking Down Gilead Sciences: 22 Analysts Share Their Views
January 29, 2025
Tickers
GILD
From Benzinga
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
January 27, 2025
From Benzinga
8 Health Care Stocks Whale Activity In Today's Session
January 20, 2025
From Benzinga
From Benzinga
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
January 09, 2025
From Benzinga
From Benzinga
From Benzinga
Marjorie Taylor Greene Went Christmas Shopping For Stocks, Here's What She Bought Before Holiday
December 31, 2024
From Benzinga
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
December 22, 2024
From Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
December 16, 2024
From Benzinga
From Benzinga
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
December 12, 2024
From Benzinga
Arcellx's Cancer Cell Therapy Shows Deep, Durable Responses With Manageable Safety Profile In Heavily Pretreated Blood Cancer Patients
December 09, 2024
From Benzinga
Looking At Gilead Sciences's Recent Unusual Options Activity
December 03, 2024
Tickers
GILD
From Benzinga
Price Over Earnings Overview: Gilead Sciences
November 25, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.